[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]ALLEMANI C,MATSUDA T,CARLO VD,et al.Global surveillance of trends in cancer survival:analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers during 2000-2014 from 322 population-based registries in 71 countries (CONCORD-3)[J].Lancet,2018,391(10125):1023-1075.
[3]ANASTASIADI Z,LIANOS GD,IGNATIADOU E,et al.Breast cancer in young women:an overview[J].Updates Surg,2017,69(3):313-317.
[4]PALIKARAS K,LIONAKI E,TAVERNARAKIS N.Balancing mitochondrial biogenesis and mitophagy to maintain energy metabolism homeostasis[J].Cell Death Differ,2015,22(9):1399-1401.
[5]PORPORATO PE,FILIGHEDDU N,PEDRO JMB,et al.Mitochondrial metabolism and cancer[J].Cell Res,2018,28(3):265-280.
[6]PELICANO H,ZHANG W,LIU J,et al.Mitochondrial dysfunction in some triple-negative breast cancer cell lines:role of mTOR pathway and therapeutic potential[J].Breast Cancer Research,2014,16(5):434.
[7]WHITLEY BN,ENGELHART EA,HOPPINS S.Mitochondrial dynamics and their potential as a therapeutic target[J].Mitochondrion,2019,49:269-283.
[8]YAPA NMB,LISNYAK V,RELJIC B,et al.Mitochondrial dynamics in health and disease[J].FEBS Letters,2021,595(8):1184-1204.
[9]YADAV N,CHANDRA D.Mitochondrial DNA mutations and breast tumorigenesis[J].Biochim Biophys Acta,2013,1836(2):336-344.
[10]VAN GISBERGEN MW,VOETS AM,STARMANS MH,et al.How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges,opportunities and models[J].Mutat Res Rev Mutat Res,2015,764:16-30.
[11]VANDER MG,CANTLEY LC,THOMPSON CB.Understanding the Warburg effect:the metabolic requirements of cell proliferation[J].Science,2009,324(5930):1029-1033.
[12]O'NEILL S,PORTER RK,MCNAMEE N,et al.2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotype[J].Sci Rep,2019,9(1):3788.
[13]GONZALEZ-MENENDEZ P,HEVIA D,MAYO JC,et al.The dark side of glucose transporters in prostate cancer:Are they a new feature to characterize carcinomas[J].Int J Cancer,2018,142(12):2414-2424.
[14]PENG J,CUI Y,XU S,et al.Altered glycolysis results in drug-resistant in clinical tumor therapy[J].Oncol Lett,2021,21(5):369.
[15]SHESTOV AA,LIU X,SER Z,et al.Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step[J].ELife,2014,3:e03342.
[16]CHRISTOFK HR,VANDER MG,WU N,et al.Pyruvate kinase M2 is a phosphotyrosine-binding protein[J].Nature,2008,452(7184):181-186.
[17]HIRSCHHAEUSER F,SATTLER UG,MUELLER-KLIESER W.Lactate:a metabolic key player in cancer[J].Cancer Res,2011,71(22):6921-6925.
[18]HUANG S,TAYLOR N,STROHER E,et al.Succinate dehydrogenase assembly factor 2 is needed for assembly and activity of mitochondrial complex II and for normal root elongation in Arabidopsis[J].Plant Journal,2013,73(3):429-441.
[19]JO S,SON M,KOH H,et al.Control of mitochondrial redox balance and cellular defense against oxidative damage by mitochondrial NADP+-dependent isocitrate dehydrogenase[J].Journal of Biological Chemistry,2001,276(19):16168-16176.
[20]BONORA M,PINTON P.The mitochondrial permeability transition pore and cancer:molecular mechanisms involved in cell death[J].Frontiers in Oncology,2014,4:302.